Check-Cap (CHEK) Stock Overview
A clinical stage medical diagnostics company, focuses on capsule-based screening technology products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
CHEK Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Check-Cap Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.61 |
| 52 Week High | US$3.13 |
| 52 Week Low | US$0.56 |
| Beta | 0.46 |
| 1 Month Change | 11.03% |
| 3 Month Change | 119.38% |
| 1 Year Change | 99.98% |
| 3 Year Change | -57.63% |
| 5 Year Change | -78.30% |
| Change since IPO | -99.88% |
Recent News & Updates
Recent updates
We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate
Jul 19
Here's Why We're Watching Check-Cap's (NASDAQ:CHEK) Cash Burn Situation
Feb 05We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate
Sep 03Here's Why We're Not Too Worried About Check-Cap's (NASDAQ:CHEK) Cash Burn Situation
May 19We Think Check-Cap (NASDAQ:CHEK) Can Afford To Drive Business Growth
Feb 03We're Hopeful That Check-Cap (NASDAQ:CHEK) Will Use Its Cash Wisely
Oct 21Check-Cap (NASDAQ:CHEK) Is In A Good Position To Deliver On Growth Plans
Jul 01We're Keeping An Eye On Check-Cap's (NASDAQ:CHEK) Cash Burn Rate
Jan 02
Shareholder Returns
| CHEK | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 23.8% | 2.5% | 3.5% |
| 1Y | 100.0% | 3.2% | 12.0% |
Return vs Industry: CHEK exceeded the US Medical Equipment industry which returned 3.5% over the past year.
Return vs Market: CHEK exceeded the US Market which returned 12.5% over the past year.
Price Volatility
| CHEK volatility | |
|---|---|
| CHEK Average Weekly Movement | 55.5% |
| Medical Equipment Industry Average Movement | 8.7% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.2% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CHEK's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CHEK's weekly volatility (56%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | David Lontini | check-cap.com |
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.
Check-Cap Ltd. Fundamentals Summary
| CHEK fundamental statistics | |
|---|---|
| Market cap | US$9.42m |
| Earnings (TTM) | -US$25.15m |
| Revenue (TTM) | n/a |
Is CHEK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHEK income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$25.15m |
| Earnings | -US$25.15m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -4.30 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did CHEK perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/28 11:26 |
| End of Day Share Price | 2025/11/26 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Check-Cap Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Keay Nakae | Chardan Capital Markets, LLC |
| Kyle Bauser | Colliers Securities |
| Yi Chen | H.C. Wainwright & Co. |